Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Olympus launches paracetamol overdose test

This article was originally published in Clinica

Executive Summary

Olympus has launched its Enzymatic Paracetamol test, designed to measure overdose of the drug, in the UK and Ireland. CE marked for sale in Europe, the test uses serum or heparinised plasma and can produce results in under 12 minutes, the Japanese firm told Clinica. It added that because the test was the first Olympus paracetamol product specifically developed for use on company's instrumentation, it has "enhanced calibration stability" over the product previously used on Olympus's equipment, Audit Diagnostics' OAR6905. It also simplifies the process for operators and produces less waste. Other paracetamol assays include Applied Biotech's point-of-care, finger-stick blood test, which was launched in the UK in 2002.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT040868

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel